General Archive
-
News releases
MRC Technology and Chinese Academy of Sciences collaboration yields humanized anti-CD146 antibody
The on-going collaboration between MRC Technology and the Institute of Biophysics, Chinese Academy of Sciences (IBP CAS) aims to develop…
-
News releases
Science and Technology Committee report on the “valley of death”
MRC Technology’s CEO, Dave Tapolczay, gave evidence to the UK House of Commons Science and Technology Committee for their enquiry…
-
News releases
MRC Technology and MS Society launch joint ‘Call for Targets’
The call aims to to fast-track the discovery and development of novel drugs to slow, stop or reverse progression in…
-
News releases
MRC Technology and AICR partnership reports success for cancer research
The partnership enables AICR to take advantage of MRC Technology’s IP management, technology transfer, and drug discovery expertise, to help…
-
News releases
MRC Technology forms alliance with world leading translational research centres to accelerate global drug development
Six of the world’s top translational health research centres have come together to form a new Global Alliance of Leading…
-
News releases
MRC Technology and Chinese Academy of Science collaborate to identify new targets for drug discovery
The collaboration will combine the SIBCB’s research expertise in generating potential new drug targets, with MRC Technology’s experience in further…
-
News releases
MRC Technology supports Parkinson’s UK through its research grant terms approval service
Parkinson’s UK is the latest medical research funder to benefit from its recently launched research grant terms approval service. As…
-
News releases
MRC Technology launches small molecule compound library access scheme
Scheme provides access to a representative subset of 9,000 compounds from 150,000 strong small molecule compound library to academic research…
-
News releases
Intellect Neurosciences and MRC Technology announce humanization of next-generation monoclonal antibody to amyloid beta with reduced potential for inflammation in the brain of Alzheimer’s patients
MRC Technology and Intellect Neurosciences have completed humanization of 82E1, a mouse monoclonal antibody to create a high-affinity stabilized IgG4…
-
News releases
New postpartum haemorrhage drug discovery project launched
A collaboration between MRC Technology and Dr Andrew Blanks at the University of Warwick has been launched to develop inhibitors…
-
News releases
GPCR collaboration with Heptares extended
The collaboration covers the structure and active conformations of G-protein coupled receptors (GPCRs), and other transmembrane proteins. Building upon their…
-
News releases
New ACTH-dependent Cushing’s Syndrome drug discovery project launched
Collaboration between MRC Technology and Queen Mary University of London to develop melanocortin receptor type 2 (MC2R) antagonists for the…